Metabolome-wide Association Study of Bronchopulmonary Dysplasia in Extremely Premature Infants
- 1University of California San Francisco
Abstract
Rationale: Untargeted metabolomics may identify novel pathways involved in bronchopulmonary dysplasia (BPD), a poorly understood lung disease in extremely premature infants. Objective: To identify metabolites and pathways altered in infants who develop BPD through a metabolome-wide association study. Methods: We performed untargeted urinary metabolomics in 314 infants (<29 weeks gestational age) at two time points between postnatal days 5-15 and 23-32, with detailed time-series for 28 infants. We compared metabolite levels between infants with and without BPD at 36 weeks postmenstrual age using logistic regression and pathway enrichment analysis. A stratified analysis by nutrition type was performed at 23-32 days. Results: Among the 913 analyzed urinary metabolites, 23 and 68 were nominally associated with BPD between postnatal days 5-15 and 23-32, respectively (p<0.05). We found enrichment in the lactoyl amino acid sub-pathway (5-15 days; p=0.005, q=0.4) and xanthine metabolism and fatty acid metabolism (23-32 days; p[≤]0.002, q<0.1). Most BPD-differential metabolites were lower in infants with BPD at days 23-32 (OR=7.1, p=2x10-6), with similar patterns among infants receiving parenteral (OR=9.2, p=7x10-7) and full enteral nutrition (OR=6.1, p=0.003). Twenty-four metabolites, including vitamins C, B1, and B6, were lower in infants on parenteral nutrition with BPD at postnatal days 23-32. Discussion: BPD in extremely premature infants was associated with lower levels of vitamin-related metabolites and dysregulation of lactoyl amino acids, xanthine, and fatty acid metabolism. BPD-differential metabolites were lower in infants with BPD during the fourth week of life, potentially related to higher energy demand, metabolic dysregulation, insufficient nutrient availability, and/or impaired intestinal absorption.
Related
- Effects of Neurally Adjusted Ventilatory Assist on Lung Ultrasound Aeration and Diaphragmatic Function in Extremely Preterm Infants With Evolving or Established Bronchopulmonary Dysplasia.
- Early Tracheal and Salivary miRNAs in Extremely Preterm Infants Predict Bronchopulmonary Dysplasia-Related Pulmonary Hypertension.
- Cord blood T-Cell imbalances as early predictors of bronchopulmonary dysplasia in extremely preterm neonates.
- Early prophylactic low-dose hydrocortisone for bronchopulmonary dysplasia prevention in extremely preterm infants: a systematic review and meta-analysis
- Reassessing bronchopulmonary dysplasia definitions: association between severity grading and brain injury on term-equivalent age MRI
BibTeX
@misc{malavemendez2026metabolomewide,
title = {{Metabolome-wide Association Study of Bronchopulmonary Dysplasia in Extremely Premature Infants}},
author = {T. I. Malave-Mendez and M. A. Guardado and C. Chapin and R. D. Hernandez and P. Ballard and D. G. Torgerson},
howpublished = {medRxiv},
year = {2026},
month = nov,
doi = {10.64898/2026.11.06.26367452},
url = {https://www.medrxiv.org/content/10.64898/2026.11.06.26367452v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - Metabolome-wide Association Study of Bronchopulmonary Dysplasia in Extremely Premature Infants
AU - T. I. Malave-Mendez
AU - M. A. Guardado
AU - C. Chapin
AU - R. D. Hernandez
AU - P. Ballard
AU - D. G. Torgerson
PY - 2026
DA - 2026/11/06
PB - medRxiv
DO - 10.64898/2026.11.06.26367452
UR - https://www.medrxiv.org/content/10.64898/2026.11.06.26367452v1
AB - Rationale: Untargeted metabolomics may identify novel pathways involved in bronchopulmonary dysplasia (BPD), a poorly understood lung disease in extremely premature infants. Objective: To identify metabolites and pathways altered in infants who develop BPD through a metabolome-wide association study. Methods: We performed untargeted urinary metabolomics in 314 infants (<29 weeks gestational age) at two time points between postnatal days 5-15 and 23-32, with detailed time-series for 28 infants. We compared metabolite levels between infants with and without BPD at 36 weeks postmenstrual age using logistic regression and pathway enrichment analysis. A stratified analysis by nutrition type was performed at 23-32 days. Results: Among the 913 analyzed urinary metabolites, 23 and 68 were nominally associated with BPD between postnatal days 5-15 and 23-32, respectively (p<0.05). We found enrichment in the lactoyl amino acid sub-pathway (5-15 days; p=0.005, q=0.4) and xanthine metabolism and fatty acid metabolism (23-32 days; p[≤]0.002, q<0.1). Most BPD-differential metabolites were lower in infants with BPD at days 23-32 (OR=7.1, p=2x10-6), with similar patterns among infants receiving parenteral (OR=9.2, p=7x10-7) and full enteral nutrition (OR=6.1, p=0.003). Twenty-four metabolites, including vitamins C, B1, and B6, were lower in infants on parenteral nutrition with BPD at postnatal days 23-32. Discussion: BPD in extremely premature infants was associated with lower levels of vitamin-related metabolites and dysregulation of lactoyl amino acids, xanthine, and fatty acid metabolism. BPD-differential metabolites were lower in infants with BPD during the fourth week of life, potentially related to higher energy demand, metabolic dysregulation, insufficient nutrient availability, and/or impaired intestinal absorption.
ER -